Literature DB >> 29388870

Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier.

MaryPeace McRae1, Lindsay M LaFratta2, Benjamin M Nguyen2, Jason J Paris3, Kurt F Hauser4, Daniel E Conway2.   

Abstract

A principal function of endothelial cells is the formation of a barrier between the blood and tissues.  This barrier arises from the physical connections at cell-cell junctions, which includes cytoskeletal tight junction and adherens junction proteins. Methods that alter barrier function must therefore affect these cell-cell connections. The blood brain barrier (BBB) represents perhaps the most selective endothelial barrier, which arises from endothelial cell interactions with astrocytes and pericytes. Even in non-central nervous system (CNS) endothelial cells, barrier properties can be enhanced, mimicking the BBB, through induction of intercellular junctions, by either direct co-culture with astrocytes, supplementation with astrocyte conditioned medium (ACM) and/or pharmacologic enhancement of cAMP. To understand how cell-cell junctions change during endothelial barrier enhancement, we examined the effects of ACM and/or cAMP donors added to standard media on human umbilical vein endothelial cells (HUVEC). HUVEC cultured with cAMP-elevating agents had the most enhanced barrier function as measured by Electric Cell-substrate Impedance Sensing (ECIS®), a real-time, label-free, impedance based method of studying cell barrier properties. However, subtle differences in actin and cell-cell junction proteins were seen across all four culture conditions. cAMP-elevating agents also triggered the redistribution of ZO-1 and VE-cadherin to cell-cell junctions, and intensified the actin microfilament network at the cell cortex.  Using a VE-cadherin FRET-force sensor, we observed a decrease in VE-cadherin force in HUVEC cultured with ACM with cAMP donors. Our data indicate cAMP elevation induces both junctional strengthening and reduced VE-cadherin forces. Additionally, treatment with an inhibitor of formin, which reduced actin stress fibers, enhanced barrier function. These data suggest that barrier function is modulated both through the trafficking of proteins to cell-cell junctions, and through the modulation and a relaxation of mechanical force through adherens junctions as intercellular junctional complexes become established.

Entities:  

Keywords:  blood-brain barrier; endothelial cells; mechanobiology; vascular endothelial- (VE-) cadherin force sensor

Mesh:

Year:  2018        PMID: 29388870      PMCID: PMC5823545          DOI: 10.1080/21688370.2017.1405774

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  35 in total

1.  Nesprin-2G, a Component of the Nuclear LINC Complex, Is Subject to Myosin-Dependent Tension.

Authors:  Paul T Arsenovic; Iswarya Ramachandran; Kranthidhar Bathula; Ruijun Zhu; Jiten D Narang; Natalie A Noll; Christopher A Lemmon; Gregg G Gundersen; Daniel E Conway
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

2.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 3.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 4.  Breaking the VE-cadherin bonds.

Authors:  Julie Gavard
Journal:  FEBS Lett       Date:  2008-12-04       Impact factor: 4.124

5.  Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier.

Authors:  Ryan C Winger; Jennifer E Koblinski; Takashi Kanda; Richard M Ransohoff; William A Muller
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

6.  Membrane configuration optimization for a murine in vitro blood-brain barrier model.

Authors:  Diane M Wuest; Allison M Wing; Kelvin H Lee
Journal:  J Neurosci Methods       Date:  2012-11-03       Impact factor: 2.390

7.  Dual role of vinculin in barrier-disruptive and barrier-enhancing endothelial cell responses.

Authors:  Anna A Birukova; Alok S Shah; Yufeng Tian; Nurgul Moldobaeva; Konstantin G Birukov
Journal:  Cell Signal       Date:  2016-02-24       Impact factor: 4.315

8.  Mechanical tugging force regulates the size of cell-cell junctions.

Authors:  Zhijun Liu; John L Tan; Daniel M Cohen; Michael T Yang; Nathan J Sniadecki; Sami Alom Ruiz; Celeste M Nelson; Christopher S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-12       Impact factor: 11.205

9.  HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice.

Authors:  Crystal R Leibrand; Jason J Paris; M Said Ghandour; Pamela E Knapp; Woong-Ki Kim; Kurt F Hauser; MaryPeace McRae
Journal:  Neurosci Lett       Date:  2017-01-03       Impact factor: 3.046

Review 10.  Endothelial adherens junctions and the actin cytoskeleton: an 'infinity net'?

Authors:  Maria Grazia Lampugnani
Journal:  J Biol       Date:  2010-04-08
View more
  9 in total

Review 1.  Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.

Authors:  Yuqing Yan; Jiezhong Yu; Ye Gao; Gajendra Kumar; Minfang Guo; Yijin Zhao; Qingli Fang; Huiyu Zhang; Jingwen Yu; Yuqiang Jiang; Han-Ting Zhang; Cun-Gen Ma
Journal:  Metab Brain Dis       Date:  2018-12-14       Impact factor: 3.584

2.  Materials for blood brain barrier modeling in vitro.

Authors:  Magali P Ferro; Sarah C Heilshorn; Roisin M Owens
Journal:  Mater Sci Eng R Rep       Date:  2020-01-06       Impact factor: 36.214

3.  A Facile Method for Generating a Smooth and Tubular Vessel Lumen Using a Viscous Fingering Pattern in a Microfluidic Device.

Authors:  Ting-Yuan Tu; Yen-Ping Shen; Sei-Hien Lim; Yang-Kao Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-02

4.  ArhGEF12 activates Rap1A and not RhoA in human dermal microvascular endothelial cells to reduce tumor necrosis factor-induced leak.

Authors:  Alamzeb Khan; Weiming Ni; Tania Baltazar; Francesc Lopez-Giraldez; Jordan S Pober; Richard W Pierce
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

5.  Src kinases relax adherens junctions between the neighbors of apoptotic cells to permit apical extrusion.

Authors:  Jessica L Teo; Vanesa M Tomatis; Luke Coburn; Anne K Lagendijk; Irin-Maya Schouwenaar; Srikanth Budnar; Thomas E Hall; Suzie Verma; Robert W McLachlan; Benjamin M Hogan; Robert G Parton; Alpha S Yap; Guillermo A Gomez
Journal:  Mol Biol Cell       Date:  2020-09-09       Impact factor: 4.138

Review 6.  Review of Design Considerations for Brain-on-a-Chip Models.

Authors:  Tiffany Cameron; Tanya Bennet; Elyn M Rowe; Mehwish Anwer; Cheryl L Wellington; Karen C Cheung
Journal:  Micromachines (Basel)       Date:  2021-04-15       Impact factor: 2.891

7.  Gelsolin impairs barrier function in pancreatic ductal epithelial cells by actin filament depolymerization in hypertriglyceridemia-induced pancreatitis in vitro.

Authors:  Hui-Ying Yang; Zhi-Hai Liang; Jin-Lian Xie; Qing Wu; Ying-Ying Qin; Shi-Yu Zhang; Guo-Du Tang
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

8.  Quantitatively relating brain endothelial cell-cell junction phenotype to global and local barrier properties under varied culture conditions via the Junction Analyzer Program.

Authors:  Kelsey M Gray; Jae W Jung; Collin T Inglut; Huang-Chiao Huang; Kimberly M Stroka
Journal:  Fluids Barriers CNS       Date:  2020-02-11

9.  Modulation of in vitro Brain Endothelium by Mechanical Trauma: Structural and Functional Restoration by Poloxamer 188.

Authors:  Edidiong Inyang; Vinay Abhyankar; Bo Chen; Michael Cho
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.